Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Autologous Stem Cell Transplant in 2 nd Line DLBCL in 2022, Still the Standard of Care ? a Monocentric Experience

Blood (2022) 140 (Supplement 1): 7712–7713.

https://doi.org/10.1182/blood-2022-158171

Published: 2022

Journal Articles

Prep@Gref: Software Streamlining for the Search for Donors for Hematopoietic Stem Cell Transplantation

Claude Lemarié, Bechara Mfarrej, Sabine Furst, Didier Blaise, Sylvie Bayona, Benjamin Bouchacourt, Boris Calmels, Raynier Devillier, Catherine Faucher, Angela Granata, Samia Harbi, Faezeh Legrand, Thomas Pagliardini, Christophe Picard, Sandrine Sow, Sophie Simon, Cécile Teste, Fluzin Sylvain, Christian Chabannon

Blood (2022) 140 (Supplement 1): 12811–12812.

https://doi.org/10.1182/blood-2022-162290

Published: 2022

Journal Articles

Higher Grade Cytokine Release Syndrome Is a Predictive Factor for Gvhd in Haploidentical Stem Cell Transplantation with Peripheral Blood Cell

Benjamin Bouchacourt, Valerio Maisano, Ana Benzaquen, Angela Granata, Sabine Furst, Faezeh Legrand, Thomas Pagliardini, Sandrine Loron, Samia Harbi, Pierre-Jean Weiller, Marie-Joelle Mozziconacci, Claude Lemarie, Boris Calmels, Christian Chabannon, Didier Blaise, Raynier Devillier

Blood (2021) 138 (Supplement 1): 2881.

https://doi.org/10.1182/blood-2021-151187

Published: 2021

Journal Articles

Successful Clearance of Donor Specific Anti-HLA Antibodies after Desensitization with Rituximab, Velcade and Plasma-Exchange Followed By a Haploidentical Stem Cell Transplantion with Post-Transplantation Cyclophosphamide

Sabine Furst, Valerio Maisano, MD, Agnes Basire, Angela Granata, MD, Faezeh Legrand, MD, Raynier Devillier, Samia Harbi, Luca Castagna, MD, Christophe Picard, Claude Lemarie, Pharm.D., Christian Chabannon, MD PhD, Didier Blaise, MD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-142473

Published: 2020

Journal Articles

Non-Myeloablative Conditioning Regimen before T-Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Lymphoma

Blood (2019) 134 (Supplement_1): 4614.

https://doi.org/10.1182/blood-2019-128004

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Patients of 65 Years or Older: A Monocenter Analysis on 252 Patients

Blood (2019) 134 (Supplement_1): 4625.

https://doi.org/10.1182/blood-2019-131845

Published: 2019

Journal Articles

Pharmacokinetic-Guided Busulfan Based Myeloablative Versus Fixed Dose Reduced Intensity Conditioning Regimen in Patients Older Than 55 Years Undergoing Allogeneic Stem Cell Transplantation for High Risk Hematological Malignancies

Margaux Damge, Sabine Furst, MD, Bénédicte Devictor, Samia Harbi, MD, Joseph Ciccolini, Angela Granata, MD, Thomas Pagliardini, MD, Boris Calmels, Pharm.D., Claude Lemarie, Pharm.D., Luca Castagna, MD, Valerio Maisano, MD, Faezeh Legrand, MD, Anne-Marie Stoppa, MD, Reda Bouabdallah, Evelyne D'Incan, Norbert Vey, MD PhD, Christian Chabannon, MD PhD, Didier Blaise, MD PhD, Raynier Devillier, MD PhD

Blood (2019) 134 (Supplement_1): 4503.

https://doi.org/10.1182/blood-2019-125994

Published: 2019

Journal Articles

Gvhd after PBSC-Haploidentical Stem Cell Transplantation (Haplo-SCT) with Post Transplantation-Cyclophosphamide (PT-Cy)

Angela Granata, MD, Raynier Devillier, Stefania Bramanti, MD, Sabine Furst, MD, Faezeh Legrand, MD, Samia Harbi, MD, Catherine Faucher, MD, Christian Chabannon, MD PhD, Claude Lemarie, Pharm.D., Boris Calmels, Pharm.D., Jacopo Mariotti, Valerio Maisano, MD, Pierre Jean Weiller, MDPhD, Luca Castagna, MD, Didier Blaise

Blood (2017) 130 (Supplement 1): 1984.

https://doi.org/10.1182/blood.V130.Suppl_1.1984.1984

Published: 2017

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Patients over 60 Years with Acute Myeloid Leukemia: A Single Center Donor Comparison

Raynier Devillier, Sabine Furst, MD, Jerome Rey, MD, Angela Granata, MD, Aude Charbonnier, MD, Samia Harbi, MD, Evelyne D'Incan, MD, Thomas Pagliardini, Catherine Faucher, MD, Claude Lemarie, Pharm.D., Colombe Saillard, MD, Faezeh Legrand, MD, Boris Calmels, Pharm.D., Bilal Mohty, MD, Valerio Maisano, MD, Christian Chabannon, MD PhD, Pierre Jean Weiller, MDPhD, Norbert Vey, Didier Blaise

Blood (2017) 130 (Supplement 1): 2038.

https://doi.org/10.1182/blood.V130.Suppl_1.2038.2038

Published: 2017

Journal Articles

Prophylactic Donor Lymphocyte Infusions after Haploidentical Hematopoietic Stem Cell Transplantation for High Risk Hematological Malignancies: A Retrospective Bicentric Analysis of Serial Infusions of Increasing Doses of CD3 + Cells

Raphaël Cauchois, Luca Castagna, MD, Samia Harbi, MD, Boris Calmels, Pharm.D., Stefania Bramanti, MD, Angela Granata, MD, Claude Lemarie, Pharm.D., Valerio Maisano, MD, Faezeh Legrand, MD, Sabine Furst, MD, Pierre Jean Weiller, MDPhD, Christian Chabannon, MD PhD, Didier Blaise, Raynier Devillier

Blood (2017) 130 (Supplement 1): 3276.

https://doi.org/10.1182/blood.V130.Suppl_1.3276.3276

Published: 2017

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Improves Outcome of Patients > 60 Years with Acute Myeloid Leukemia in First Complete Remission: A 10-Year Single Center Transplantation Program Analysis

Raynier Devillier, Jerome Rey, MD, Samia Harbi, MD, Aude Charbonnier, MD, Sabine Furst, MD, Colombe Saillard, MD, Angela Granata, MD, Evelyne D'Incan, MD, Catherine Faucher, MD, Claude Lemarie, Pharm.D., Faezeh Legrand, MD, Boris Calmels, Pharm.D., Valerio Maisano, MD, Bilal Mohty, MD, Christian Chabannon, MD PhD, Pierre Jean Weiller, MDPhD, Didier Blaise, Norbert Vey

Blood (2017) 130 (Supplement 1): 3327.

https://doi.org/10.1182/blood.V130.Suppl_1.3327.3327

Published: 2017

Journal Articles

Chimerism Analysis after Haploidentical Stem Cell Transplantation: Is It Necessary for All Patients?

Faezeh Legrand, MD, Valerio Maisano, MD, Sabine Fürst, MD, Angela Granata, MD, Marie Joelle Mozziaconacci, MD, Catherine Faucher, MD, Claude Lemarie, PharmD, Samia Harbi, MD, Christophe Picard, MD PhD, Stephania Bramanti, MD, Boris Calmels, PharmD, PhD, Christian Chabannon, MD PhD, Raynier Devillier, MD PhD, Didier Blaise, MD PhD

Blood (2016) 128 (22): 3417.

https://doi.org/10.1182/blood.V128.22.3417.3417

Published: 2016

Journal Articles

Pretransplantation Myeloablative Conditioning Regimen with Intravenous Busulfan Dose Adjustment for Older Patients with Hematologic Malignancies

Sabine Fürst, MD, Jean El Cheikh, MD PhD, Bénédicte Devictor, MD, Sandra Cournier, Angela Granata, MD, Samia Harbi, MD, Raynier Devillier, MD PhD, Faezeh Legrand, MD, Stefania Bramanti, MD, Claude Lemarie, PharmD, Jean Pierre Weiller, MD, Catherine Faucher, MD, Christian Chabannon, MD PhD, Borje S. Andersson, MD PhD, Didier Blaise, MD PhD

Blood (2016) 128 (22): 5751.

https://doi.org/10.1182/blood.V128.22.5751.5751

Published: 2016

Journal Articles

Low Incidence of Chronic Gvhd after Haploidentical T-Cell Replete Peripheral Blood Stem Cell Transplantation with Post Transplantation Cyclophosphamide (PT-Cy)

Angela Granata, MD, Sabine Furst, MD, Jean marie Boher, Luca Castagna, MD, Patrice Chevallier, MD PhD, Alice Garnier, MD, Thierry Guillaume, MD PhD, Remy Dulery, MD, Mohamad Mohty, Faezeh Legrand, Samia Harbi, MD, Raynier Devillier, MD PhD, Catherine Faucher, MD, Stefania Bramanti, MD, Claude Lemarie, PharmD, Boris Calmels, PharmD, PhD, Pierre Jean Weiller, MD, Christian Chabannon, MD PhD, Didier Blaise, MD PhD

Blood (2016) 128 (22): 4594.

https://doi.org/10.1182/blood.V128.22.4594.4594

Published: 2016

Journal Articles

Successfull Engraftment and Clearance of Donor Specific Antibodies after Haploidentical Related Stem Cell Transplantation for an Adult Patient with Sickle Cell Disease

Sabine FÜrst, MD, Emmanuelle Bernit, MD, Jean El Cheikh, MD, Angela Granata, MD, Samia Harbi, MD, Bilal Mohty, MD, Laurence Caymaris, Head Nurse, Claude Lemarie, MD, Boris Calmels, PharmD, PhD, Christian Chabannon, MD PhD, Christophe Picard, Djamel Mokart, MD PhD, Borje Andersson, MD PhD, Didier Blaise, MD

Blood (2014) 124 (21): 5792.

https://doi.org/10.1182/blood.V124.21.5792.5792

Published: 2014

Journal Articles

Impact of Pretransplant Donor and Recipient Cytomegalovirus Serostatus On Outcome for Multiple Myeloma Patients Undergoing Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

Jean El-Cheikh, MD PhD, Raynier Devillier, Roberto Crocchiolo, MD PhD, Sabine Furst, MD, Boris Calmels, Catherine Faucher, Anne Marie Stoppa, MD, Angela Granata, Claire Oudin, Patrick Ladaique, Claude Lemarie, Geoffroy Venton, Reda Bouabdallah, MD, Christine Zandotti, Pierre Berger, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 4496.

https://doi.org/10.1182/blood.V120.21.4496.4496

Published: 2012

Journal Articles

High Response RATE and NO Treatment Related Mortality After Brentuximab Vedotin Salvage Therapy Followed by Reduced Intensity Conditioning Regimen Allogeneic STEM CELL Transplantation (RIC-ALLO) in Patients with CD 30+ Lymphomas

Sabine Furst, MD, Reda Bouabdallah, MD, Diane Coso, MD, Roberto Crocchiolo, MD PhD, Jean El-Cheikh, MD PhD, Catherine Faucher, MD, Angela Granata, Claire Oudin, Geoffroy Venton, Anne Marie Stoppa, Claude Lemarie, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 4526.

https://doi.org/10.1182/blood.V120.21.4526.4526

Published: 2012

Journal Articles

Fully Automated Washing of Cryopreserved Peripheral Blood Stem Cells (PBSC): Results of a Prospective, Multicenter, Clinical Trial.

Riccardo Saccardi, MD, Miguel Blanquer, MD, Margherita Boieri, Christoph Bucher, MD, Christian Chabannon, MD, PhD, Simone Dal Pozzo, Benjamin Esterni, Ph.D., Francesco Lanza, MD, Claude Lemarie, Maria Dolores Lopez Lucas, Doris Loutan, Jose M Morelada Jimenez, Andre Tichelli, MD, Boris Calmels

Blood (2012) 120 (21): 3164.

https://doi.org/10.1182/blood.V120.21.3164.3164

Published: 2012

Journal Articles

The Addition of ONE-Day Rest Between LAST ATG Infusion and STEM CELL Infusion DID NOT Affect Gvhd Occurrence After Allogeneic TRANSPLANTATION with Fludarabine-Busulfan-ATG Conditioning.

Roberto Crocchiolo, MD PhD, Sabine Fuerst, MD, Jean El-Cheikh, MD PhD, Angela Granata, Claire Oudin, Geoffroy Venton, Norbert Vey, Reda Bouabdallah, MD, Anne Marie Stoppa, Florence Broussais, MD, Aude Charbonnier, MD, PhD, Claude Lemarie, Diane Coso, MD, Thomas Prebet, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 3029.

https://doi.org/10.1182/blood.V120.21.3029.3029

Published: 2012

Journal Articles

LOW Tranplant Related Mortality and LOW GRAFT Rejection After Related Haploidentical STEM CELL Transplantation (HAPLO-SCT) Prepared with NON Myeloablative CONDITIONING REGIMEN (NMA) and Posttransplant Cyclophosphamide for Advanced Lymphoid Malignancies.

Sabine Furst, MD, Roberto Crocchiolo, MD PhD, Jean El-Cheikh, MD PhD, Catherine Faucher, MD, Claire Oudin, Angela Granata, Geoffroy Venton, Claude Lemarie, Diane Coso, MD, Reda Bouabdallah, MD, Anne Marie Stoppa, Norbert Vey, Christian Chabannon, MD, PhD, Didier Blaise, MD

Blood (2012) 120 (21): 3031.

https://doi.org/10.1182/blood.V120.21.3031.3031

Published: 2012

NARROW

Autologous Stem Cell Transplant in 2 nd Line DLBCL in 2022, Still the Standard of Care ? a Monocentric Experience

Prep@Gref: Software Streamlining for the Search for Donors for Hematopoietic Stem Cell Transplantation

Higher Grade Cytokine Release Syndrome Is a Predictive Factor for Gvhd in Haploidentical Stem Cell Transplantation with Peripheral Blood Cell

Successful Clearance of Donor Specific Anti-HLA Antibodies after Desensitization with Rituximab, Velcade and Plasma-Exchange Followed By a Haploidentical Stem Cell Transplantion with Post-Transplantation Cyclophosphamide

Non-Myeloablative Conditioning Regimen before T-Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Lymphoma

Allogeneic Hematopoietic Stem Cell Transplantation in Patients of 65 Years or Older: A Monocenter Analysis on 252 Patients

Pharmacokinetic-Guided Busulfan Based Myeloablative Versus Fixed Dose Reduced Intensity Conditioning Regimen in Patients Older Than 55 Years Undergoing Allogeneic Stem Cell Transplantation for High Risk Hematological Malignancies

Gvhd after PBSC-Haploidentical Stem Cell Transplantation (Haplo-SCT) with Post Transplantation-Cyclophosphamide (PT-Cy)

Allogeneic Hematopoietic Stem Cell Transplantation for Patients over 60 Years with Acute Myeloid Leukemia: A Single Center Donor Comparison

Prophylactic Donor Lymphocyte Infusions after Haploidentical Hematopoietic Stem Cell Transplantation for High Risk Hematological Malignancies: A Retrospective Bicentric Analysis of Serial Infusions of Increasing Doses of CD3 + Cells

Allogeneic Hematopoietic Stem Cell Transplantation Improves Outcome of Patients > 60 Years with Acute Myeloid Leukemia in First Complete Remission: A 10-Year Single Center Transplantation Program Analysis

Chimerism Analysis after Haploidentical Stem Cell Transplantation: Is It Necessary for All Patients?

Pretransplantation Myeloablative Conditioning Regimen with Intravenous Busulfan Dose Adjustment for Older Patients with Hematologic Malignancies

Low Incidence of Chronic Gvhd after Haploidentical T-Cell Replete Peripheral Blood Stem Cell Transplantation with Post Transplantation Cyclophosphamide (PT-Cy)

Successfull Engraftment and Clearance of Donor Specific Antibodies after Haploidentical Related Stem Cell Transplantation for an Adult Patient with Sickle Cell Disease

Impact of Pretransplant Donor and Recipient Cytomegalovirus Serostatus On Outcome for Multiple Myeloma Patients Undergoing Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation

High Response RATE and NO Treatment Related Mortality After Brentuximab Vedotin Salvage Therapy Followed by Reduced Intensity Conditioning Regimen Allogeneic STEM CELL Transplantation (RIC-ALLO) in Patients with CD 30+ Lymphomas

Fully Automated Washing of Cryopreserved Peripheral Blood Stem Cells (PBSC): Results of a Prospective, Multicenter, Clinical Trial.

The Addition of ONE-Day Rest Between LAST ATG Infusion and STEM CELL Infusion DID NOT Affect Gvhd Occurrence After Allogeneic TRANSPLANTATION with Fludarabine-Busulfan-ATG Conditioning.

LOW Tranplant Related Mortality and LOW GRAFT Rejection After Related Haploidentical STEM CELL Transplantation (HAPLO-SCT) Prepared with NON Myeloablative CONDITIONING REGIMEN (NMA) and Posttransplant Cyclophosphamide for Advanced Lymphoid Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only